WOLVERINE TRADING, LLC - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 235 filers reported holding AXSOME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.6%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,927,832
-28.0%
41,892
-24.7%
0.00%
-60.0%
Q2 2023$4,066,861
+130793.5%
55,619
+8.4%
0.01%0.0%
Q1 2023$3,107
-32.6%
51,300
-14.2%
0.01%
-28.6%
Q4 2022$4,613
-99.8%
59,820
+3.2%
0.01%
+75.0%
Q3 2022$2,560,00057,9790.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders